CYTODYN INC. DL -,01 WKN: A0YHA5 ISIN: US23283M1018 Kürzel: 296 Forum: Aktien Thema: Hauptdiskussion

0,325 USD
-1,52 % -0,005
17:41:47 Uhr, Nasdaq OTC
Kommentare 2.792
FCINGO
FCINGO, 07.10.2020 20:37 Uhr
0
Also könnte es in den nächsten Wochen los gehen , Zeit wird es .
CompanyFlow
CompanyFlow, 07.10.2020 20:30 Uhr
0
I was able to re-wind my Sirius..trying to transcribe..He was indeed on Fox with Cavouto. Here are the highlights. Started at 1:51 PM EST - Cavuoto - "very positive results" He bungled Leronlimab. - Nader - explains Leronlimab...not new to FDA...Dr. Fauci spoke positively about monclonal antibodies. Fantastic results in CD 10...end of next week announcement of CD 12 results...think the results will be fantastic...fast track designation for HIV and Cancer. - Cavuoto - You got FDA attention...FDA tightening trials, safety. Might delay approvals - Nader - We have done 1000 patients with spectacular safety. End of next week 195 patient results...Hope for approval from MHRA and FDA That is it. Nader did pretty good. Very positivte
CompanyFlow
CompanyFlow, 07.10.2020 20:30 Uhr
0
Hier ein Auszug bzw kurze Zusammenfassung
CompanyFlow
CompanyFlow, 07.10.2020 20:30 Uhr
0
Scheint recht positiv gewesen zu sein
CompanyFlow
CompanyFlow, 07.10.2020 15:57 Uhr
0
Schauen wir mal. Vielleicht pusht das den Kurs ein bisschen 😊
CompanyFlow
CompanyFlow, 07.10.2020 15:56 Uhr
0
Heute ist ein großartiger Tag. Wir haben den sehr angesehenen Dr. Harish Seethamraju, Ärztlicher Direktor, Advanced Lung Failure und Lungentransplantation, Montefiore Medical Center NYC, der die Wissenschaft und den Erfolg von Leronlimab auf der speziellen isirv-antiviralen Gruppenkonferenz über Therapeutika für COVID-19 vorstellt . Er ist nicht mit CYDY verbunden und würde sicherlich nicht den Ruf und die Karriere einer Droge aufs Spiel setzen, an die er nicht glaubt. Nein, dies ist kein Schlangenöl, es ist eine Droge mit erstaunlichen Versprechungen gegen Covid, HIV, Krebs und mehr
Rize53
Rize53, 05.10.2020 8:46 Uhr
0
👀
Egwhacker
Egwhacker, 03.10.2020 12:38 Uhr
0
https://www.eventbrite.co.uk/e/special-isirv-avg-virtual-conference-on-therapeutics-for-covid-19-registration-112933852192
FCINGO
FCINGO, 02.10.2020 21:27 Uhr
0
Wäre schon froh wenn es wieder kontinuierlich steigt .😉
Egwhacker
Egwhacker, 02.10.2020 19:52 Uhr
0
@Fcingo stell dir vor Leronlimab rettet Donald das Leben 👍Dann geht der Kurs durch die Decke 😂
Egwhacker
Egwhacker, 02.10.2020 19:48 Uhr
0
Ich denke viele Anleger glauben das Leronlimab bei Trump jetzt ins Spiel kommt 😉😂
FCINGO
FCINGO, 02.10.2020 17:39 Uhr
0
Was ist hier los , alles rot und Cytodyn Grün ? Hab ich was verpasst 🤔
CompanyFlow
CompanyFlow, 01.10.2020 15:39 Uhr
0
After plenty of DD and good posts I've read I've honestly taken a bit from everyone and came to a strong conclusion. First, You have to understand that NP is a man of passion. You have to understand what he means, not necessarily exactly what he says.... And he is limited to what he can say but he talks to us often because of shorts and AFvckery. DD: 1st) Cytodyn needed the share holders to vote in favor for more talent to expand. This is good because the shorts can't drive our Ceo out of town and let BP buy Cytodyn for cheap. That was a BIG WIN. They tried to make it seem like it was bad news but the whole time they wanted us to vote No. Literally today on national news was the first HIV cured patient that died. It's very unfortunate, may you rip... But imagine when this blows up and they mention this also is the HIV monotherapy drug but also possibly the cure with the Dr that cured him. National News. 2) NPs last CC focused on the EIND for a reason because he knew that we would likely only be told about the deaths. DD brings us to know that 15% of people died on the EIND trial and much fewer Sae's. Which is significantly better than Remdesiver. Sadly, 45-50 died. We don't know if placebo or LeronLimab had them in. On our first EIND we were given patients that were literally a day or two from dying because it was to my understanding LeronLimab was a last hope. That is no longer the case because we are now on phase 3 with other big boys and now likely have better patients in the severe (imo). Therefore, we would land less than 15% or about the same. Which imo, would halt the trial, which would Grant EUA or approval. Don't get caught with your shorts down. 3) Our safety net is HIV and it's pretty much FDA 100% in the ceo's eyes. That immediately brings us to a great position at the end of the year or great Q1 no matter what the SP is or if we have to wait for this trial to finish. The science is there for HIV. Covid-19 is just the bonus. 4) licensing agreements are actually going well since two are in the works. And Philippines was probably helped by Dr. BEEN. 5) cytodyn had 3,500 share holders last year and now about 43,000. Guys, that's a whopping n 12x more people.... Think of how much we will get when Nasdaq uplisting happens and why Nader checks everyday at 6am. We literally had a cc from several inquiries about nasdaq so they can buy. 6) 11 Big Pharmas!!! I would be sweating if I was a short or feel horrible if I sold any time soon. Don't let them tell you we've been hearing that for months. We haven't. 7) Our primary end point for covid-19 will be met with interim analysis and if not, it will be by the end of the trial. As we seen from Gilead, and we have a much better drug than them, they changed end points mid trial of phase 3. We can always do that as a possibility by I taking more patients with the help of the UK. 8) again look at the Philippines Section. It says with just the cd10... It's already pursuing the EUA.... 9) if indications for stroke are great indications. The future could possibly have a huge storage in hospitals for strong patients when they're rushed to the hospitals. And being a first responder, that's honestly one of my favorite indications for this drug because of the possibilities. Thats like tylenol for people, but with such a good track record maybe even better. There are no therapies for this, which will improve the life of many out there. And with the Safety on healthy patients from the phase 2 trial, it will only make this easier to get approval by the FDA (imo). 10) 3 publications submitted by 3 highly respected doctors.
CompanyFlow
CompanyFlow, 01.10.2020 15:39 Uhr
0
Danke.. Ich habe eine ledigliche, aber dennoch interessante Ansicht und Zusammenfassung aus dem yahoo forum gefunden.
FCINGO
FCINGO, 01.10.2020 12:16 Uhr
0
Ich kann noch nichts finden Jamil
CompanyFlow
CompanyFlow, 01.10.2020 11:10 Uhr
0
Geschwafel
Meistdiskutiert
Thema
1 PLUG POWER Hauptdiskussion +13,94 %
2 RHEINMETALL Hauptdiskussion -1,77 %
3 Investmentchancen +5,56 %
4 NVIDIA Hauptdiskussion +3,13 %
5 Diginex -2,31 %
6 für alle, die es ehrlich meinen beim Traden.
7 GAMESTOP Hauptdiskussion -3,30 %
8 Dax Prognose -0,27 %
9 Beyond Meat Hauptdiskussion -0,31 %
10 Das neue Dax Prognose Forum -0,27 %
Alle Diskussionen
Aktien
Thema
1 PLUG POWER Hauptdiskussion +13,44 %
2 RHEINMETALL Hauptdiskussion -1,82 %
3 Investmentchancen +5,30 %
4 NVIDIA Hauptdiskussion +3,08 %
5 Diginex -2,31 %
6 GAMESTOP Hauptdiskussion -3,30 %
7 Beyond Meat Hauptdiskussion -1,55 %
8 SERVICENOW Hauptdiskussion +0,82 %
9 Max Power Mining Hauptdiskussion +5,40 %
10 Pyrum Innovations +0,38 %
Alle Diskussionen